SANDRA ARIAS: Open Payments
NPI 1417787805 · WESLEY CHAPEL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,667 in 75 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $631 · 2025 $1,667
Food & beverage: $1,667
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $496 |
| Janssen Biotech, Inc. | 7 | $286 |
| Madrigal Pharmaceuticals | 10 | $176 |
| PFIZER INC. | 9 | $175 |
| Ardelyx, Inc. | 9 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $107 |
| Novo Nordisk Inc | 3 | $92 |
| Aimmune Therapeutics, Inc. | 2 | $53 |
| Phathom Pharmaceuticals, Inc. | 2 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
Products named: TREMFYA, REZDIFFRA, CREON, SKYRIZI, IBSRELA, ENTYVIO, XELJANZ, Wegovy.
Industry payments across FL — which companies pay providers there.
